Skip to main content
Caplight Logo









Mend

Mend

Private
New York City, New YorkHealthcare & Life Scienceshttps://mend.me

Last Round

Early Funding

Oct 9, 2026

Total Funding Raised

$15M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Mend is a life sciences company that develops clinical nutritional products and digital health solutions designed to support surgical recovery and improve patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Mental Health, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

telehealth platformpatient engagementperioperative nutritionvirtual careclinical nutritionno-show reductionsurgical supportbehavioral health softwareremote patient monitoringRPMdigital healthhealthcare SaaScare coordinationclinical workflow automationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mend Comparables

Compare Mend with similar companies based on industry and business-model similarity.

Mend comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Force Therapeutics
82%
SeamlessMD
81%
Doxy.me
77%

Mend Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 9, 2026
Series AJun 6, 2023
SeedDec 27, 2020
SeedJul 27, 2016

Key People

Founding team and executive leadership

Eziah Syed

Founder And CEO

Founding Team

Adam Tichelaar

Chief Technology Officer

Executive Team

Mend Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 9, 2026

    $1.5M raised in early funding.

  • Sep 12, 2026

    Monthly visitors increased 30% MoM.

Mend Filings

Explore SEC and related filing metadata, where available.

Mend filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mend's valuation, stock price, and market status.

Is Mend a public or private company?

Mend is a private company.

What is the current stock price of Mend?

Mend is a private company, so its shares have no public market price. Caplight tracks Mend's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mend worth (valuation)?

Valuation information for Mend is not publicly available.

Can I buy Mend stock?

Mend shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mend's last funding round?

Mend's most recent funding round was Early Funding on October 9, 2026.

Who are the main investors in Mend?

Key investors in Mend include S2G Investments, Backswing Ventures.

Will Mend IPO soon?

No public IPO plans have been announced for Mend.

How can I track Mend secondary market activity?

Caplight tracks bids, offers, and trades in Mend's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range44
Year Founded2018
Last FundingOct 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?